Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer.

Journal of genetic counseling - 1 Apr 2009

Hamilton Rebekah, Williams Janet K, Bowers Barbara J, Calzone Kathleen

Abstract excerpt

This qualitative study identified four life trajectories that influenced the decision in young women to have genetic testing for mutations in BRCA1/2 and subsequent risk reduction decisions after receiving a positive mutation result. Fifty nine women between the ages of 18-39 years were interviewed in this grounded theory study, 44 of those tested were found to have a mutation in either BRCA1 or BRCA2. Of those...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Mutation

Share to Ovarian Neoplasms

Share to Risk Reduction Behavior

Source

Open in PubMed Open full text

Identifiers

PMID: 18979190
DOI: 10.1007/s10897-008-9200-1
PMCID: PMC2834272

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer.PMID 18979190Read ↗

Living With Genetic Vulnerability: a Life Course Perspective.Semantic proximity Read ↗

Longitudinal cancer risk management trajectories of BRCA1/2 mutation-positive reproductive-age women.Semantic proximity Read ↗

Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

Danger zones: risk perceptions of young women from families with hereditary breast and ovarian cancer.Semantic proximity Read ↗

Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutations.Semantic proximity Read ↗

Reproductive decision-making in young female carriers of a BRCA mutation.Semantic proximity Read ↗

Cancer risk management decision making for BRCA+ women.Semantic proximity Read ↗

In their own words: treating very young BRCA1/2 mutation-positive women with care and caution.Semantic proximity Read ↗

Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction.Semantic proximity Read ↗

A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25.Semantic proximity Read ↗

“I need to know if I’m going to die young”: Adolescent and young adult experiences of genetic testing for Li–Fraumeni syndromeSemantic proximity Read ↗

Beating the biological clock: the compressed family life cycle of young women with BRCA gene alterations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.